Haruhito Sugiyama

InstitutionNational Center for Global Health and Medicine
AddressTokyo
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 20 Covid-19 publications, with a maximum of 4 publications in April 2021
    All Publications
    Bar chart showing 90 publications over 16 distinct years, with a maximum of 10 publications in 2012 and 2020 and 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tsukada A, Suzuki M, Kishino Y, Misumi K, Igari T, Nakajima N, Sato Y, Suzuki T, Katsuno T, Kusaba Y, Tsujimoto Y, Sakamoto K, Hashimoto M, Terada J, Takasaki J, Izumi S, Hojo M, Sugiyama H. A Kidney Transplant Patient Who Died of COVID-19-associated Severe Acute Respiratory Distress Syndrome. Intern Med. 2021 Jul 15; 60(14):2297-2300. PMID: 34053986.
      Citations:    Fields:    Translation:Humans
    2. Yamamoto S, Tanaka A, Oshiro Y, Ishii M, Ishiwari H, Konishi M, Matsuda K, Ozeki M, Miyo K, Maeda K, Mizoue T, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N. Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan. J Infect. 2021 08; 83(2):237-279. PMID: 34044036.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Kokudo N, Sugiyama H. Hospital capacity during the COVID-19 pandemic. Glob Health Med. 2021 Apr 30; 3(2):56-59. PMID: 33937565.
      Citations: 3     
    4. Saito S, Hayakawa K, Mikami A, Izumi S, Funazaki H, Ashida S, Sugiura W, Sugiyama H, Kokudo N, Ohmagari N. Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan. Glob Health Med. 2021 Apr 30; 3(2):62-66. PMID: 33937567.
      Citations: 1     
    5. Hojo M, Terada-Hirashima J, Sugiyama H. COVID-19 and bronchial asthma: current perspectives. Glob Health Med. 2021 Apr 30; 3(2):67-72. PMID: 33937568.
      Citations:    
    6. Yamamoto S, Tanaka A, Kobayashi S, Oshiro Y, Ozeki M, Maeda K, Matsuda K, Miyo K, Mizoue T, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N. Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, Japan. Glob Health Med. 2021 Apr 30; 3(2):90-94. PMID: 33937571.
      Citations:    
    7. Katsuno T, Suzuki M, Hojo M, Terada J, Nakamura K, Suzuki T, Miyazato Y, Sugiyama H. Clinical experience with high-flow nasal cannulas for coronavirus disease 2019 patients in Japan. Respir Investig. 2021 07; 59(4):569-572. PMID: 33824095.
      Citations:    Fields:    Translation:Humans
    8. Tsujimoto Y, Terada J, Kimura M, Moriya A, Motohashi A, Izumi S, Kawajiri K, Hakkaku K, Morishita M, Saito S, Takumida H, Watanabe H, Tsukada A, Morita C, Yamaguchi Y, Katsuno T, Kusaba Y, Sakamoto K, Hashimoto M, Suzuki M, Takasaki J, Hojo M, Miyoshi-Akiyama T, Sugiyama H. Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR. Infect Dis (Lond). 2021 08; 53(8):581-589. PMID: 33760699.
      Citations: 4     Fields:    Translation:Humans
    9. Maeda K, Higashi-Kuwata N, Kinoshita N, Kutsuna S, Tsuchiya K, Hattori SI, Matsuda K, Takamatsu Y, Gatanaga H, Oka S, Sugiyama H, Ohmagari N, Mitsuya H. Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma. Sci Rep. 2021 03 10; 11(1):5563. PMID: 33692457.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    10. Tanaka A, Yamamoto S, Miyo K, Mizoue T, Maeda K, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N. Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan. J Infect. 2021 04; 82(4):e1-e3. PMID: 33524423.
      Citations: 8     Fields:    Translation:Humans
    11. Terada-Hirashima J, Suzuki M, Uemura Y, Hojo M, Mikami A, Sugiura W, Ohmagari N, Sugiyama H. Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial. JMIR Res Protoc. 2020 Dec 31; 9(12):e23830. PMID: 33206053.
      Citations: 3     
    12. Katagiri D, Ishikane M, Asai Y, Izumi S, Takasaki J, Katsuoka H, Kondo I, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Kinoshita N, Ogawa T, Togano T, Suzuki M, Hashimoto M, Sakamoto K, Kusaba Y, Katsuno T, Fukaya T, Hojo M, Sugiyama M, Mizokami M, Okamoto T, Kimura A, Noiri E, Ohmagari N, Hinoshita F, Sugiyama H. Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19. J Clin Apher. 2021 Jun; 36(3):313-321. PMID: 33325084.
      Citations: 7     Fields:    Translation:Humans
    13. Sugiyama M, Kinoshita N, Ide S, Nomoto H, Nakamoto T, Saito S, Ishikane M, Kutsuna S, Hayakawa K, Hashimoto M, Suzuki M, Izumi S, Hojo M, Tsuchiya K, Gatanaga H, Takasaki J, Usami M, Kano T, Yanai H, Nishida N, Kanto T, Sugiyama H, Ohmagari N, Mizokami M. Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene. 2021 Jan 15; 766:145145. PMID: 32941953.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    14. Kusaba Y, Izumi S, Takasaki J, Suzuki M, Katagiri D, Katsuno T, Matsumoto S, Sakamoto K, Hashimoto M, Ohmagari N, Katano H, Suzuki T, Hojo M, Sugiyama H. Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion. Intern Med. 2020 Oct 01; 59(19):2405-2408. PMID: 32863364.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    15. Katagiri D, Ishikane M, Asai Y, Kinoshita N, Ota M, Moriyama Y, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Okuhama A, Kanda K, Wakimoto Y, Morioka S, Saito S, Yamamoto K, Ujiie M, Hayakawa K, Kustuna S, Yanagawa Y, Terada J, Takasaki J, Izumi S, Hojo M, Hinoshita F, Sugiyama M, Noiri E, Mizokami M, Ohmagari N, Sugiyama H. Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor. 2020 Aug; 2(8):e0170. PMID: 32766565.
      Citations: 4     
    16. Katsuno T, Suzuki M, Ishikane M, Kinoshita N, Tsukada A, Morita C, Kusaba Y, Sakamoto K, Yamaguchi Y, Tsujimoto Y, Hashimoto M, Terada J, Takasaki J, Izumi S, Okuhama A, Ide S, Moriyama Y, Matsuda K, Takamatsu Y, Mitsuya H, Hojo M, Sugiyama H. A familial cluster of severe coronavirus disease 2019 that required intubation of all family members. Infect Dis (Lond). 2020 10; 52(10):755-758. PMID: 32615051.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    17. Nakamura K, Ide S, Saito S, Kinoshita N, Kutsuna S, Moriyama Y, Suzuki T, Ota M, Nomoto H, Mizoue T, Hojo M, Takasaki J, Asai Y, Terada M, Akiyama Y, Miyazato Y, Nakamoto T, Wakimoto Y, Ujiie M, Yamamoto K, Ishikane M, Morioka S, Hayakawa K, Sugiyama H, Ohmagari N. COVID-19 can suddenly become severe: a case series from Tokyo, Japan. Glob Health Med. 2020 Jun 30; 2(3):174-177. PMID: 33330803.
      Citations: 1     
    18. Citations: 4     
    19. Kokudo N, Sugiyama H. Call for international cooperation and collaboration to effectively tackle the COVID-19 pandemic. Glob Health Med. 2020 Apr 30; 2(2):60-62. PMID: 33330778.
      Citations: 4     
    20. Hayakawa K, Kutsuna S, Kawamata T, Sugiki Y, Nonaka C, Tanaka K, Shoji M, Nagai M, Tezuka S, Shinya K, Saito H, Harada T, Moriya N, Tsuboi M, Norizuki M, Sugiura Y, Osanai Y, Sugiyama M, Okuhama A, Kanda K, Wakimoto Y, Ujiie M, Morioka S, Yamamoto K, Kinoshita N, Ishikane M, Saito S, Moriyama Y, Ota M, Nakamura K, Nakamoto T, Ide S, Nomoto H, Akiyama Y, Suzuki T, Miyazato Y, Gu Y, Matsunaga N, Tsuzuki S, Fujitomo Y, Kusama Y, Shichino H, Kaneshige M, Yamanaka J, Saito M, Hojo M, Hashimoto M, Izumi S, Takasaki J, Suzuki M, Sakamoto K, Hiroi Y, Emoto S, Tokuhara M, Kobayashi T, Tomiyama K, Nakamura F, Ohmagari N, Sugiyama H. SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine. Glob Health Med. 2020 Apr 30; 2(2):107-111. PMID: 33330786.
      Citations: 5     
    Sugiyama's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (146)
    Explore
    _
    Co-Authors (158)
    Explore
    _
    Similar People (60)
    Explore
    _